Multimodal imaging of nanovaccine carriers targeted to human dendritic cells

Molecular Pharmaceutics

Volumn 8, Issue 2, 2011, Pages 520-531

  Cruz, Luis J ^a   Tacken, Paul J ^a   Bonetto, Fernando ^a   Buschow, Sonja I ^a   Croes, Huib J ^a   Wijers, Mietske ^a   De Vries, I Jolanda ^a   Figdor, Carl G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

biocompatible materials; contrast agents; dentritic cells; fluorescence; imaging; magnetic resonance imaging; nanocarriers; nanoparticles

Indexed keywords

ANTIGEN; CD209 ANTIGEN; COLLAGEN; CONTRAST MEDIUM; FLUORESCEIN ISOTHIOCYANATE; LYSYLLYSYLGLUTAMINYLTYROSYLISOLEUCYLLYSYLALANYLASPARAGINYLSERYLLYSYLPHENYLALANYLISOLEUCYLGLYCYLISOLEUCYLTHREONYLGLUTAMYLLEUCYLLYSYLLYSINE; MOLECULAR SCAFFOLD; NANOCARRIER; POLYGLACTIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; VACCINE;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL MIGRATION; CELL ORGANELLE; CONFOCAL MICROSCOPY; CYTOPLASM; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYSOSOME; MOLECULAR IMAGING; NANOENCAPSULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANTIGEN PRESENTATION; BLOOD CELLS; CELL ADHESION MOLECULES; DENDRITIC CELLS; DRUG CARRIERS; FERRIC COMPOUNDS; FLOW CYTOMETRY; HUMANS; LACTIC ACID; LECTINS, C-TYPE; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; NANOTECHNOLOGY; PEPTIDE FRAGMENTS; POLYGLYCOLIC ACID; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; VACCINES, SUBUNIT;

EID: 79953820808     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100356k     Document Type: Article

References (41)

1. Lesterhuis, W. J.; Aarntzen, E. H.; De Vries, I. J.; Schuurhuis, D. H.; Figdor, C. G.; Adema, G. J.; Punt, C. J. Dendritic cell vaccines in melanoma: from promise to proof? Crit. Rev. Oncol. Hematol. 2008, 66 (2), 118-34.
2. Adema, G. J.; de Vries, I. J.; Punt, C. J.; Figdor, C. G. Migration of dendritic cell based cancer vaccines: in vivo veritas? Curr. Opin. Immunol. 2005, 17 (2), 170-4.
3. Tacken, P. J.; de Vries, I. J.; Torensma, R.; Figdor, C. G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 2007, 7 (10), 790-802.
4. De Vries, I. J.; Krooshoop, D. J.; Scharenborg, N. M.; Lesterhuis, W. J.; Diepstra, J. H.; Van Muijen, G. N.; Strijk, S. P.; Ruers, T. J.; Boerman, O. C.; Oyen, W. J.; Adema, G. J.; Punt, C. J.; Figdor, C. G. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003, 63 (1), 12-7. (Pubitemid 36070411)
5. de Vries, I. J.; Lesterhuis, W. J.; Barentsz, J. O.; Verdijk, P.; van Krieken, J. H.; Boerman, O. C.; Oyen,W. J.; Bonenkamp, J. J.; Boezeman, J. B.; Adema, G. J.; Bulte, J. W.; Scheenen, T. W.; Punt, C. J.; Heerschap, A.; Figdor, C. G. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005, 23 (11), 1407-13.
6. Olasz, E. B.; Lang, L.; Seidel, J.; Green, M. V.; Eckelman, W. C.; Katz, S. I. Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. J. Immunol. Methods 2002, 260 (1-2), 137-48. (Pubitemid 34132880)
7. Schimmelpfennig, C. H.; Schulz, S.; Arber, C.; Baker, J.; Tarner, I.; McBride, J.; Contag, C. H.; Negrin, R. S. Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation. Am. J. Pathol. 2005, 167 (5), 1321-31.
8. Baumjohann, D.; Hess, A.; Budinsky, L.; Brune, K.; Schuler, G.; Lutz, M. B. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur. J. Immunol. 2006, 36 (9), 2544-55.
9. Verdijk, P.; Scheenen, T. W.; Lesterhuis, W. J.; Gambarota, G.; Veltien, A. A.; Walczak, P.; Scharenborg, N. M.; Bulte, J. W.; Punt, C. J.; Heerschap, A.; Figdor, C. G.; de Vries, I. J. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int. J. Cancer 2007, 120 (5), 978-84.
10. Jain, T. K.; Richey, J.; Strand, M.; Leslie-Pelecky, D. L.; Flask, C. A.; Labhasetwar, V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008, 29 (29), 4012-21.
11. Reichardt, W.; Durr, C.; von Elverfeldt, D.; Juttner, E.; Gerlach, U. V.; Yamada, M.; Smith, B.; Negrin, R. S.; Zeiser, R. Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation. J. Immunol. 2008, 181 (7), 4770-9.
12. Lim, Y. T.; Noh, Y. W.; Han, J. H.; Cai, Q. Y.; Yoon, K. H.; Chung, B. H. Biocompatible polymer-nanoparticle-based bimodal imaging contrast agents for the labeling and tracking of dendritic cells. Small 2008, 4 (10), 1640-5.
13. Ngaboni Okassa, L.; Marchais, H.; Douziech-Eyrolles, L.; Cohen-Jonathan, S.; Souce, M.; Dubois, P.; Chourpa, I. Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles. Int. J. Pharm. 2005, 302 (1-2), 187-96.
14. Okassa, L. N.; Marchais, H.; Douziech-Eyrolles, L.; Herve, K.; Cohen-Jonathan, S.; Munnier, E.; Souce, M.; Linassier, C.; Dubois, P.; Chourpa, I. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles. Eur. J. Pharm. Biopharm. 2007, 67 (1), 31-8.
15. Beaune, G.; Dubertret, B.; Clement, O.; Vayssettes, C.; Cabuil, V.; Menager, C. Giant vesicles containing magnetic nanoparticles and quantum dots: feasibility and tracking by fiber confocal fluorescence microscopy. Angew. Chem., Int. Ed. 2007, 46 (28), 5421-4. (Pubitemid 47067648)
16. McCarthy, J. R.; Jaffer, F. A.; Weissleder, R. A macrophage-targeted theranostic nanoparticle for biomedical applications. Small 2006, 2 (8-9), 983-7. (Pubitemid 44230996)
17. Mulder, W. J.; Griffioen, A. W.; Strijkers, G. J.; Cormode, D. P.; Nicolay, K.; Fayad, Z. A. Magnetic and fluorescent nanoparticles for multimodality imaging. Nanomedicine (London) 2007, 2 (3), 307-24.
18. Uzgiris, E. E.; Sood, A.; Bove, K.; Grimmond, B.; Lee, D.; Lomnes, S. A multimodal contrast agent for preoperative MR Imaging and intraoperative tumor margin delineation. Technol. Cancer Res. Treat. 2006, 5 (4), 301-9.
19. Veiseh, O.; Sun, C.; Gunn, J.; Kohler, N.; Gabikian, P.; Lee, D.; Bhattarai, N.; Ellenbogen, R.; Sze, R.; Hallahan, A.; Olson, J.; Zhang, M. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett. 2005, 5 (6), 1003-8.
20. Harisinghani, M. G.; Dixon, W. T.; Saksena, M. A.; Brachtel, E.; Blezek, D. J.; Dhawale, P. J.; Torabi, M.; Hahn, P. F. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 2004, 24 (3), 867-78. (Pubitemid 38703252)
21. Lu, C. W.; Hung, Y.; Hsiao, J. K.; Yao, M.; Chung, T. H.; Lin, Y. S.; Wu, S. H.; Hsu, S. C.; Liu, H. M.; Mou, C. Y.; Yang, C. S.; Huang, D. M.; Chen, Y. C. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett. 2007, 7 (1), 149-54.
22. O'Hagan, D. T.; Rahman, D.; McGee, J. P.; Jeffery, H.; Davies, M. C.; Williams, P.; Davis, S. S.; Challacombe, S. J. Biodegradable microparticles as controlled release antigen delivery systems. Immunology 1991, 73 (2), 239-42.
23. Gupta, A. K.; Gupta, M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 2005, 26 (13), 1565-73. (Pubitemid 39441388)
24. Martina, M. S.; Nicolas, V.; Wilhelm, C.; Menager, C.; Barratt, G.; Lesieur, S. The in vitro kinetics of the interactions between PEG-ylated magnetic-fluid-loaded liposomes and macrophages. Biomaterials 2007, 28 (28), 4143-53. (Pubitemid 47049811)
25. Quaranta, V.; Walker, L. E.; Pellegrino, M. A.; Ferrone, S. Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent. J. Immunol. 1980, 125 (4), 1421-5. (Pubitemid 10018539)
26. Tacken, P. J.; de Vries, I. J.; Gijzen, K.; Joosten, B.; Wu, D.; Rother, R. P.; Faas, S. J.; Punt, C. J.; Torensma, R.; Adema, G. J.; Figdor, C. G. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 2005, 106 (4), 1278-85. (Pubitemid 41129591)
27. Thomas, T. C.; Rollins, S. A.; Rother, R. P.; Giannoni, M. A.; Hartman, S. L.; Elliott, E. A.; Nye, S. H.; Matis, L. A.; Squinto, S. P.; Evans, M. J. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol. Immunol. 1996, 33 (17-18), 1389-401.
28. Houghten, R. A.; Bray, M. K.; Degraw, S. T.; Kirby, C. J. Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavages of protected peptide resins. Int. J. Pept. Protein Res. 1986, 27 (6), 673-8.
29. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970, 34 (2), 595-8.
30. Kumar, C. S.; Leuschner, C.; Doomes, E. E.;Henry, L.; Juban,M.; Hormes, J. Efficacy of lytic peptide-bound magnetite nanoparticles in destroying breast cancer cells. J. Nanosci. Nanotechnol. 2004, 4 (3), 245-9.
31. Cruz, L. J.; Tacken, P. J.; Fokkink, R.; Joosten, B.; Stuart, M. C.; Albericio, F.; Torensma, R.; Figdor, C. G. J. Controlled Release 2010, 144 (2), 118-26.
32. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-54.
33. Vitiello, A.; Ishioka, G.; Grey, H. M.; Rose, R.; Farness, P.; LaFond, R.; Yuan, L.; Chisari, F. V.; Furze, J.; Bartholomeuz, R.; et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 1995, 95 (1), 341-9.
34. Cruz, L. J.; Iglesias, E.; Aguilar, J. C.; Gonzalez, L. J.; Reyes, O.; Albericio, F.; Andreu, D. A comparative study of different presentation strategies for an HIV peptide immunogen. Bioconjugate Chem. 2004, 15 (1), 112-20. (Pubitemid 38165987)
35. Borras-Cuesta, F.; Fedon, Y.; Petit-Camurdan, A. Enhancement of peptide immunogenicity by linear polymerization. Eur. J. Immunol. 1988, 18 (2), 199-202.
36. Huang, S. H.; Liao, M. H.; Chen, D. H. Direct binding and characterization of lipase onto magnetic nanoparticles. Biotechnol. Prog. 2003, 19 (3), 1095-100.
37. Verdijk, P.; Aarntzen, E. H.; Lesterhuis, W. J.; Boullart, A. C.; Kok, E.; van Rossum, M. M.; Strijk, S.; Eijckeler, F.; Bonenkamp, J. J.; Jacobs, J. F.; Blokx, W.; Vankrieken, J. H.; Joosten, I.; Boerman, O. C.; Oyen, W. J.; Adema, G.; Punt, C. J.; Figdor, C. G.; de Vries, I. J. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin. Cancer Res. 2009, 15 (7), 2531-40.
38. Panyam, J.; Zhou, W. Z.; Prabha, S.; Sahoo, S. K.; Labhasetwar, V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 2002, 16 (10), 1217-26. (Pubitemid 34815409)
39. Shen, H.; Ackerman, A. L.; Cody, V.; Giodini, A.; Hinson, E. R.; Cresswell, P.; Edelson, R. L.; Saltzman, W. M.; Hanlon, D. J. Immunology 2006, 117 (1), 78-88.
40. Kim, D. H.; Martin, D. C. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 2006, 27 (15), 3031-7. (Pubitemid 43208929)
41. Lee, P. W.; Hsu, S. H.; Wang, J. J.; Tsai, J. S.; Lin, K. J.; Wey, S. P.; Chen, F. R.; Lai, C. H.; Yen, T. C.; Sung, H. W. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 31 (6), 1316-24.